期刊文献+

HCVC区基因在SP2/0细胞及荷瘤小鼠瘤内的表达 被引量:4

HCV core protein expression in SP2/0 cell and BALB/c mouse plasmacytoma
下载PDF
导出
摘要 目的 观察HCVC区基因在SP2 / 0细胞及荷瘤小鼠瘤内的表达情况 .方法 构建pEF HCVC重组质粒 ,转染SP2 / 0细胞 ,经G4 18进行筛选 ,建立稳定转染pEF HCVC的SP2 / 0细胞系 .并将转染后的SP2 / 0细胞接种于BALB/c小鼠皮下产生浆细胞瘤 .结果 用斑点杂交方法检测转染后的细胞 ,有HCVmRNA .免疫组化检测瞬时转染以及稳定转染的SP2 / 0细胞涂片均发现存在有阳性信号 .另外 ,对瘤组织进行免疫组化检测 ,发现有HCVC蛋白表达 .结论 pEF HCVC重组质粒可以在SP2 / 0细胞中长期稳定表达 ,也可以在BALB/c小鼠浆细胞瘤内表达 . AIM To observe the expression of HCV core protein in SP2/0 cell and BALB/c mouse plasmacytoma. METHODS The recombinant plasmid pEF HCV was constructed and transfected into SP2/0 cells. After SP2/0 cells were screened by G418, a cell model with stable expression was established. The transfected SP2/0 cells were inoculated subcutaneously into the right and left flank of the syngeneic BALB/c mice to develop plamacytoma tumors. RESULTS Positive signals were detected by blot hybridization in SP2/0 transfected with pEF HCV. The cell besmears of SP2/0 cells transfected with pEF HCV core instantaneously and stably were detected by immunohistochemical staining. Positive signals were found in all the samples. Such was the case in SP2/0 plasmacytoma tumors. CONCLUSION Recombinant pEF HCV core can express stably in SP2/0 cells and BALB/c mouse plasmacytoma, and this model can be used as an animal model to evaluate the effects of anti HCV agents.
出处 《第四军医大学学报》 北大核心 2002年第24期2236-2239,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金资助项目 (3980 0 1 2 1 )
关键词 HCVC区基因 SP2/0细胞 荷瘤小鼠 丙型肝炎 基因表达 hepatitis c like viruses nucleoproteins gene expression disease models, animal
  • 相关文献

参考文献3

二级参考文献6

共引文献42

同被引文献24

  • 1韩苏夏,李华,潘承恩,杨广笑,王全颖.丙型肝炎病毒核心蛋白在鼠肝中表达的诱癌作用[J].第四军医大学学报,2004,25(20):1828-1830. 被引量:2
  • 2张志培,王文亮,邓中荣,王文勇,李擒龙,王丽.HCV核心蛋白,p53,Mdm2,p14^(ARF)在HCV肝炎肝硬化的表达及相关性[J].第四军医大学学报,2005,26(12):1097-1100. 被引量:8
  • 3宋丽萍,邱曙东.蛋白质转导结构介导的细胞转运[J].中华肿瘤防治杂志,2006,13(14):1112-1114. 被引量:1
  • 4Kao CF, Chen SY, Chen JY, et al. Modulation of p53 transcription regulatory activity and post translational modification by hepatitis C virus core protein [ J]. Oncogene, 2004,23 (14) :2472 - 2483.
  • 5Munsie M, O'brien C, Mountford P. Transgenic strategy for demonstrating nuclear reprogramming in the mouse [J].Cloning Stem Cells,2002,4(2) : 121 - 130.
  • 6Li K, Wang L, Cheng J, et al. Interaction between hepatitis C virus core protein and translin protein-a possible molecular mechanism for hepatocellnlar carcinoma and lymphoma caused by hepatitis C virus [J]. World J Gastroenterol,2003,9 ( 2 ) :300 - 303.
  • 7Jin DY, Wang HL, Zhou Y. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation [ J ]. EMBO J, 2000, 19(4) : 729 -740.
  • 8Jarver P, Lange IU. The use of cell-penetrating peptides as a tool for gene regulation [ J ]. Drug Discov Today,2004,9 ( 9 ) :395 - 402.
  • 9Hugle T,Cerny A.Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C[J].Rev Med Virol,2003,13:361-371.
  • 10YangJ.[D].第四军医大学,2005:56-58.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部